Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 3812424, 11 pages
https://doi.org/10.1155/2018/3812424
Research Article

Prostaglandin E1 Preconditioning Attenuates Liver Ischemia Reperfusion Injury in a Rat Model of Extrahepatic Cholestasis

Department of Hepatobiliary and Spleen Surgery, Shengjing Hospital Affiliated to China Medical University, Shenyang, Liaoning 110004, China

Correspondence should be addressed to Chaoliu Dai; moc.361@js_lciad

Received 28 September 2017; Accepted 14 December 2017; Published 8 January 2018

Academic Editor: Thomas Minor

Copyright © 2018 Feng Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Yan, N. Lu, W. Tian, and T. Liu, “Evolution of surgery for Klatskin tumor demonstrates improved outcome: A single center analysis,” TUMORI, vol. 100, no. 6, pp. e250–e256, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Wang, Z.-M. Geng, X.-G. Song et al., “Concomitant precise hemihepatectomy to improve the efficacy of surgical treatment for hilar cholangiocarcinoma: analysis of 38 cases,” Hepato-Gastroenterology, vol. 61, no. 132, pp. 927–932, 2014. View at Google Scholar · View at Scopus
  3. H. Yoshidome, M. Miyazaki, H. Shimizu et al., “Obstructive jaundice impairs hepatic sinusoidal endothelial cell function and renders liver susceptible to hepatic ischemia/reperfusion,” Journal of Hepatology, vol. 33, no. 1, pp. 59–67, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. J. J. Kloek, H. A. Marsman, A. K. van Vliet, D. J. Gouma, and T. M. van Gulik, “Biliary drainage attenuates postischemic reperfusion injury in the cholestatic rat liver,” Surgery, vol. 144, no. 1, pp. 22–31, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. J. J. Kloek, X. Maréchal, J. Roelofsen et al., “Cholestasis is associated with hepatic microvascular dysfunction and aberrant energy metabolism before and during ischemia-reperfusion,” Antioxidants & Redox Signaling, vol. 17, no. 8, pp. 1109–1123, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Kawasaki, H. Imamura, A. Kobayashi, T. Noike, S. Miwa, and S.-I. Miyagawa, “Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization,” Annals of Surgery, vol. 238, no. 1, pp. 84–92, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. J.-J. Xiong, Q. M. Nunes, W. Huang et al., “Preoperative biliary drainage in patients with hilar cholangiocarcinoma undergoing major hepatectomy,” World Journal of Gastroenterology, vol. 19, no. 46, pp. 8731–8739, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Abdel Wahab, E. El Hanafy, A. El Nakeeb, E. Hamdy, E. Atif, and A. M. Sultan, “Postoperative outcome after major liver resection in jaundiced patients with proximal bile duct cancer without preoperative biliary drainage,” Digestive Surgery, vol. 32, no. 6, pp. 426–432, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Suyavaran and C. Thirunavukkarasu, “Preconditioning methods in the management of hepatic ischemia reperfusion- induced injury: update on molecular and future perspectives,” Hepatology Research, vol. 47, no. 1, pp. 31–48, 2017. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Maida, Y. Akamatsu, Y. Hara et al., “Short oxygenated warm perfusion with prostaglandin E1 administration before cold preservation as a novel resuscitation method for liver grafts from donors after cardiac death in a rat in vivo model,” Transplantation, vol. 100, no. 5, pp. 1052–1058, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Hafez, M. Moussa, I. Nesim, N. Baligh, B. Davidson, and A. Abdul-Hadi, “Nitric oxide inhalation improves microvascular flow and decreases infarction size after myocardial ischemia and reperfusion,” Journal of Surgical Research, vol. 138, no. 1, pp. 88–99, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Hara, Y. Akamatsu, K. Maida et al., “A new liver graft preparation method for uncontrolled non-heart-beating donors, combining short oxygenated warm perfusion and prostaglandin E1,” Journal of Surgical Research, vol. 184, no. 2, pp. 1134–1142, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Machiki, Y. Nimura, H. Kanda et al., “Effects of prostaglandin E1 on hepatic blood flow in conscious dogs with chronic biliary obstruction,” European Surgical Research, vol. 30, no. 2, pp. 115–124, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Xu, C.-L. Dai, S.-L. Peng et al., “Polymyxin B protects against hepatic ischemia/reperfusion injury in a rat model of obstructive jaundice,” Inflammation, vol. 37, no. 4, pp. 1015–1021, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Suzuki, L. H. Toledo-Pereyra, F. J. Rodriguez, and D. Cejalvo, “Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine,” Transplantation, vol. 55, no. 6, pp. 1265–1272, 1993. View at Publisher · View at Google Scholar · View at Scopus
  16. C. H. Ketchum, C. A. Robinson, L. M. Hall, and W. E. Grizzle, “Lactate dehydrogenase isolated from human liver mitochondria: its purification and partial biochemical characterization,” Clinical Biochemistry, vol. 21, no. 4, pp. 231–237, 1988. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Rej, “Aminotransferases in disease,” Clinics in Laboratory Medicine, vol. 9, no. 4, pp. 667–687, 1989. View at Google Scholar
  18. M. Radojkovic, M. Stojanovic, G. Stanojevic et al., “Ischemic preconditioning vs adenosine vs prostaglandin E1 for protection against liver ischemia/reperfusion injury,” Brazilian Journal of Medical and Biological Research, vol. 50, no. 8, 2017. View at Publisher · View at Google Scholar
  19. A. R. Knudsen, K. J. Andersen, S. Hamilton-Dutoit, J. R. Nyengaard, and F. V. Mortensen, “Correlation between liver cell necrosis and circulating alanine aminotransferase after ischaemia/reperfusion injuries in the rat liver,” International Journal of Clinical and Experimental Pathology, vol. 97, no. 2, pp. 133–138, 2016. View at Publisher · View at Google Scholar
  20. K. Schrör and T. Hohlfeld, “Mechanisms of anti-ischemic action of prostaglandin E1 in peripheral arterial occlusive disease,” Vasa—Journal of Vascular Diseases, vol. 33, no. 3, pp. 119–124, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. T. T. Yang, S. J. Song, H. B. Xue, D. F. Shi, C. M. Liu, and H. Liu, “Regulatory T cells in the pathogenesis of type 2 diabetes mellitus retinopathy by miR-155,” European Review for Medical and Pharmacological Sciences, vol. 19, no. 11, pp. 2010–2015, 2015. View at Google Scholar
  22. W.-S. Deng, Q. Xu, Y. Liu, C.-H. Jiang, H. Zhou, and L. Gu, “Effects of melatonin on liver function and lipid peroxidation in a rat model of hepatic ischemia/reperfusion injury,” Experimental and Therapeutic Medicine, vol. 11, no. 5, pp. 1955–1960, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Bulbuller, Z. Cetinkaya, M. A. Akkus et al., “The effects of melatonin and prostaglandin E1 analogue on experimental hepatic ischaemia reperfusion damage,” International Journal of Clinical Practice, vol. 57, no. 10, pp. 857–860, 2003. View at Google Scholar
  24. N. Teoh, J. Field, J. Sutton, and G. Farrell, “Dual role of tumor necrosis factor-α in hepatic ischemia-reperfusion injury: studies in tumor necrosis factor-α gene knockout mice,” Hepatology, vol. 39, no. 2, pp. 412–421, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Wang, S. Wu, X. Yu et al., “Dexmedetomidine protects rat liver against ischemia-reperfusion injury partly by the α2A-adrenoceptor subtype and the mechanism is associated with the TLR4/NF-κB pathway,” International Journal of Molecular Sciences, vol. 17, no. 7, article 995, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Chen, J. Li, S. Li et al., “15-Deoxy-Δ12,14-prostaglandin J2 alleviates hepatic ischemia-reperfusion injury in mice via inducing antioxidant response and inhibiting apoptosis and autophagy,” Acta Pharmacologica Sinica, vol. 38, no. 5, pp. 672–687, 2017. View at Publisher · View at Google Scholar
  27. B. C. Perry, D. Soltys, A. H. Toledo, and L. H. Toledo-Pereyra, “Tumor necrosis factor-α in liver ischemia/reperfusion injury,” Journal of Investigative Surgery, vol. 24, no. 4, pp. 178–188, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Cory, D. C. S. Huang, and J. M. Adams, “The Bcl-2 family: roles in cell survival and oncogenesis,” Oncogene, vol. 22, no. 53, pp. 8590–8607, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. S. P. Junnarkar, N. Tapuria, A. Mani et al., “Attenuation of warm ischemia-reperfusion injury in the liver by bucillamine through decreased neutrophil activation and Bax/Bcl-2 modulation,” Journal of Gastroenterology and Hepatology, vol. 25, no. 12, pp. 1891–1899, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. Z. Ben-Ari, O. Pappo, Y. Cheporko et al., “Bax ablation protects against hepatic ischemia/reperfusion injury in transgenic mice,” Liver Transplantation, vol. 13, no. 8, pp. 1181–1188, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Marie Hardwick and L. Soane, “Multiple functions of BCL-2 family proteins,” Cold Spring Harbor Perspectives in Biology, vol. 5, no. 2, 2013. View at Publisher · View at Google Scholar · View at Scopus